Lewis, K.; Peris, K.; Sekulic, A.; Stratigos, A.; Dunn, L.; Eroglu, Z.; Chang, A. L.; Migden, M.; Li, S.; Yoo, S.-Y.; Mohan, K.; Coates, E.; Okoye, E.; Baurain, J.-F.; Bechter, O.; Hauschild, A.; Butler, M.; Hernandez-Aya, L.; Licitra, L.; Neves, R.; Ruiz, E.; Seebach, F.; Lowy, I.; Bowler, T.; Fury, M. Interim Analysis of Phase 2 Results for Cemiplimab in Patients With Metastatic Basal Cell Carcinoma (mBCC) Who Progressed on or Are Intolerant to Hedgehog Inhibitors (HHIs). J of Skin 2021, 5, s3.